Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk

Presentations in This Video

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk - Chair

Elaine W Yu, MD

Massachusetts General Hospital, MA, United States

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk - Transitions in Osteoporosis Pharmacotherapy

Benjamin Z Leder, MD

Massachusetts General Hospital, MA, United States

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk - Sclerostin Inhibition for the Treatment of Osteoporosis

Suzanne M Jan De Beur, MD

Johns Hopkins University School of Medicine, MD, United States

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk - Treatment Options for Individuals at Moderate Fracture Risk

Ian Reid, FRACP

University of Auckland, New Zealand

Related Media